$GTHX "G1 Therapeutics (NASDAQ:GTHX) jumped 19% amid some takeover speculation. There's speculation that G1 Therapeutics (GTHX) has received and rejected multiple approaches from TerSera Therapeutics according to a Betaville "uncooked" alert on Thursday, which cited people following the matter. TerSera is said to have submitted an indicative offer for GTHX of between $5 and $7 a share, according to the report. The offer from TerSera, which is owned by private equity firm GRCR, is rumored to have a contingent value right, that could value the company at $ 12 and $14 a share. G1 Therapeutics (GTHX) told Seeking Alpha in an email that it doesn't comment on rumors or speculation." Продал половину там, где ещё есть возможность продать - получилось +80% в долларах - воспоминания о нормальной интересной торговле на мировых площадках. Остальное, если до 7 дойдёт. Слухи мутные, почему бы не слить на них. Очень плохо, что основная часть заморожена, цензурных слов нет по этому поводу.